Table 1.

Summary of the relation between the relative expression of isoforms

ManipulationRelative Homer expression in mPFCBasal glutamate contentCocaine-stimulated releaseCocaine rewardCocaine locomotion
mPFCNACmPFCNAC
Repeated i.p. cocaineHomer2 > Homer1abcbcde
Repeated i.v. cocaineHomer2 > Homer1f,ghcgccMixedi
Homer1 KOHomer2 > Homer1j,klj,kllj,k,l
mPFC cDNA-H2bHomer2 > Homer1
mPFC shRNA-H1cHomer2 > Homer1n.d.n.d.
Homer2 KOHomer2 < Homer1ll,mllll
mPFC shRNA-H2bHomer2 < Homer1
mPFC cDNA-H1cHomer2 < Homer1kn.d.kn.d.n.d.k
  • Data are reported as the relative expression of mPFC Homer1 versus Homer2 isoforms produced by either repeated cocaine experience (intraperitoneal or intravenous administration) or transgenic manipulations of Homer protein expression within drug-naive animals; and (1) the levels of basal extracellular glutamate within the mPFC and the NAC; (2) the change in extracellular glutamate levels within the mPFC and NAC produced by a cocaine challenge injection; (3) indices of cocaine reward or reinforcement (i.e., conditioned place-preference or intravenous cocaine self-administration); and (4) cocaine-stimulated locomotor behavior or locomotor sensitization. ↑ and ↓, Increase and decrease, respectively, relative to animals treated acutely with drug (for repeated intraperitoneal or intravenous cocaine administration), WT controls (for Homer1 and Homer2 KO mice), or animals infused with a control AAV (for cDNA and shRNA-infused animals); —, no change from aforementioned controls; cDNA-H2b, AAV carrying Homer2b cDNA; n.d., not determined.

  • aAry and Szumlinski (2007).

  • bWilliams and Steketee (2004).

  • cBaker et al. (2003).

  • dLett et al. (1989).

  • eVanderschuren and Kalivas (2000).

  • fGould et al. (submitted).

  • gBen-Shahar et al. (2012).

  • hBen-Shahar et al. (2013).

  • iBen-Shahar et al. (2004).

  • jSzumlinski et al. (2005a).

  • kLominac et al. (2005).

  • lSzumlinski et al. (2004).

  • mSzumlinski et al. (2005b).